Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power

March 13, 2025 updated by: Kyriaki Antoniou, University of Central Lancashire Cyprus
This crossover-design study examines the acute effect of taurine on trained individuals aged 18-40 on strength and power outputs.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The purpose of this study is to further investigate any potential ergogenic effects offered by taurine, under specific conditions, namely that of acute supplementation, as opposed to the chronic supplementation protocols of many popular ergogenic aids, such as creatine and beta alanine. Exercise modes investigated include maximal isometric strength, maximal instantaneous power generation, and sustained maximal anaerobic power output, investigated via grip strength, vertical jump height, and the Wingate test, respectively.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Cyprus
    • Pyla
      • Larnaca, Pyla, Cyprus, 7080
        • University of Central Lancashire Cyprus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • participants 18 - 40 years of age
  • physically active or recreationally active with consistent training more than 3 times per week for at least 6 months
  • non-smokers

Exclusion Criteria:

  • cardiovascular, respiratory or metabolic diseases
  • any musculoskeletal injury in the last six months
  • taking taurine and/or creatine supplementation in the past three months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Taurine supplementation
Participants consumed 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink.
Dietary supplement: Taurine supplementation
For the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.
Placebo Comparator: Placebo
Placebo was a 500ml sugar-free lemonade drink with nothing added
Dietary supplement: Placebo
For the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Maximal Isometric strength in kilograms assessed via handgrip test
Time Frame: Day 1
Day 1
Relative Isometric strength in kilograms assessed via handgrip test
Time Frame: Day 1
Day 1
Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.
Time Frame: Day 1
Day 1
Average Instantaneous power generation in W/kg assessed via vertical jump height test.
Time Frame: Day 1
Day 1
Peak power in Watts assessed via the Wingate Anaerobic test
Time Frame: Day 1
Day 1
Maximal Isometric strength in kilograms assessed via handgrip test
Time Frame: After 48 hours
After 48 hours
Relative Isometric strength in kilograms assessed via handgrip test
Time Frame: After 48 hours
After 48 hours
Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.
Time Frame: After 48 hours
After 48 hours
Average Instantaneous power generation in W/kg assessed via vertical jump height test.
Time Frame: After 48 hours
After 48 hours
Peak power in Watts assessed via the Wingate Anaerobic test
Time Frame: After 48 hours
After 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Central Lancashire Cyprus

Investigators

  • Principal Investigator: Efstathios Christodoulides, PhD, https://www.uclancyprus.ac.cy/

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2025

Primary Completion (Actual)

January 21, 2025

Study Completion (Actual)

January 21, 2025

Study Registration Dates

First Submitted

January 23, 2025

First Submitted That Met QC Criteria

March 13, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 13, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ΕΕΒΚ/ΕΠ/2024/76

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe